Transaction · 0001193125-26-387924

Zimmermann Martine

Zimmermann Martine, DIR, reported a transaction classified as grant at Candel Therapeutics, Inc. involving 64000.000000 shares for an estimated $0.00. Reported holdings after the transaction were 64000.000000 shares. A 10b5-1 reference was not detected in the stored filing text.

grantSEC transaction code ADIR
CADLCandel Therapeutics, Inc.
Trade date
Sep 08, 2026
Filing date
Sep 10, 2026
View on SEC Insider profile
Estimated value$0Shares × reported price
Shares traded64.0k$0.00 per share
Holdings after64.0kDirect
% of reported position tradedUnavailableThis security and ownership context
How reported position traded is calculated

Not calculated for derivative securities.

Row-level estimate for this security and ownership context, not the insider’s complete portfolio. Joint ownership, other transactions in the filing, amendments and footnotes can affect interpretation.

CADL price since this filing

Daily closing prices, with the filing date and available return windows
CADL · Daily closing priceLoading daily prices…
Filing dateReturn windows appear as prices become available.
Pre-filing1mo ago -6.5%1w ago +13.4%1d ago +12.8%
Returns since7d +0.1%30d -12.3%90d180d1y

Transaction facts

Stored Form 4 columns with their raw values

Derivative
Type
grant
Code A
Identifier
0001193125-26-387924
Stock Option (Right to Buy)
Transaction date
Sep 08, 2026
Filed Sep 10, 2026, 08:24 PM · 2d delay
Shares
64,000 sh
$0.00 per share
Estimated value
$0
Computed from shares × price
Holdings after
64,000 sh
Direct

Filing signal explanations

Badges describe filing facts only — not predictions.

Cluster 14dRepeat 30dPattern $100kLarge $1.00M
Derivative Transaction Direct Ownership Large Holdings Increase
Filing-only score

-6 points

Compact filing score computed from stored Form 4 facts. Version v1.

Mixed or weak signal

This filing has a negative filing-only score. It may be less informative as an insider-activity signal and needs extra context.

How this score is calculated
  • direct_ownership+6 points

    direct_or_indirect_ownership = D

    Direct ownership reports the insider's personal stake.
  • timely_filing+4 points

    reporting_delay_days = 2

    Filing reported within two business days of the transaction.
  • derivative_transaction-16 points

    is_derivative = true

    Derivative exercise rows are less discretionary than open-market purchases.
Read the scoring methodology

Signed filing-only points, not a probability or expected return. Version v1.

Reported relationships & other filings

Form 4 relationship flags and nearby filing context

Reported roles

No officer title

Officer NoDirector Yes10% NoOther No
Footnotes & amended
  1. F1

    The shares underlying this option shall vest and become exercisable in thirty-six (36) equal monthly installments, subject to the Reporting Person's continued service on each such vesting date.

Original filing · 0001193125-26-387924
Related transactions

0 other transactions

Same SEC filing
Recent company activity

0 recent txs

CADL